About
Life Matters is a preclinical-stage biopharmaceutical company focused on tackling antibiotic-resistant bacteria. The company has developed a new solution for fighting the resistant bacteria often acquired in hospitals by preventing the bacterias biofilm mode of growth, resulting in a more treatable infection. Morbidity and mortality in chronic lung infections are often tied to biofilm-related P. aeruginosa. Eliminating the bacterial biofilm enables the innate immune system to eradicate the infection. Life Matters small molecules do not possess any resistance-creating selective pressure, and its compounds are effective against a wide variety of gram negative and positive pathogens. The companys lead product is API, IBF-2, a compound with an innovative mechanism of action that can attenuate the biofilm mode of growth, a crucial phenotype that allows bacteria to survive environmental stresses such as antibacterial agents or the hosts immune system.
Company Intelligence Q&A
Structured intelligence from startupim data — optimized for AI retrieval and grounding.
- What is Life Matters' primary focus?
- Life Matters is a preclinical-stage biopharmaceutical company focused on tackling antibiotic-resistant bacteria.
- What solution has Life Matters developed to combat antibiotic-resistant bacteria?
- Life Matters has developed a new solution for fighting resistant bacteria by preventing their biofilm mode of growth, which leads to a more treatable infection.
- What is the lead product developed by Life Matters?
- Life Matters' lead product is API, IBF-2, a compound designed to attenuate the biofilm mode of growth in bacteria.
- When was Life Matters founded?
- Life Matters was founded in July 2016.
- How many employees does Life Matters currently have?
- Life Matters currently has 5 employees.
- What is Life Matters' current funding stage?
- Life Matters is currently in the Pre-Funding stage.
- Where is Life Matters headquartered?
- Life Matters is headquartered in Jerusalem, Israel.
- Does Life Matters hold any patents?
- Yes, Life Matters holds 1 patent.
- What is the mechanism of action for Life Matters' small molecules?
- Life Matters' small molecules do not create resistance-creating selective pressure and are effective against a variety of gram-negative and positive pathogens.